Last reviewed · How we verify
injected insulin
Injected insulin works by mimicking the action of the body's natural insulin hormone, helping to lower blood sugar levels.
Injected insulin works by mimicking the action of the body's natural insulin hormone, helping to lower blood sugar levels. Used for Type 1 diabetes, Type 2 diabetes.
At a glance
| Generic name | injected insulin |
|---|---|
| Sponsor | Eli Lilly and Company |
| Drug class | insulin |
| Target | insulin receptor |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
Injected insulin is a type of exogenous insulin that is administered via injection to help regulate blood sugar levels in individuals with diabetes. It works by binding to insulin receptors on cells, triggering a response that allows glucose to enter the cells and be used for energy. This helps to lower blood sugar levels and prevent complications associated with high blood sugar.
Approved indications
- Type 1 diabetes
- Type 2 diabetes
Common side effects
- Hypoglycemia
- Allergic reactions
Key clinical trials
- INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes (PHASE2)
- Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars (NA)
- Intervention for Children With Type 1 Diabetes Targeting Gut Microbes (NA)
- The Effects Of Virtual Reality and Stress Ball Application on Pain, Anxiety Levels and Injection Satisfaction in During Insulin Injection in Geriatric Patients With Type 2 Diabetes (NA)
- Coolsense and Buzzy Use on Pain Score and Anxiety Level During Insulin Injection Application (NA)
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (PHASE2)
- Avoidance of Insulin-induced Lipohypertophy in People With Diabetes Using Ultrasound Scanning Within Diabetes Clinics (NA)
- Shot Blocker and Manual Pressure Application (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- injected insulin CI brief — competitive landscape report
- injected insulin updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI